# Mereo BioPharma Group plc: filings

MREO · Nasdaq · CIK 1719714 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mreo.md) · [Financials](/companies/mreo/financials.md) · [Filings](/companies/mreo/filings.md) · [Insiders](/companies/mreo/insiders.md)

## Reports and events: 186 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 123, 4 64, SC 13G/A 30, 8-K 26, 3 15, SC 13D/A 15, SC 13G 15, SCHEDULE 13G/A 14, 144 12, 425 11, CORRESP 9, EFFECT 9, UPLOAD 9, 10-Q 8, S-8 8, 144/A 5, 20-F 5, 424B5 4, SCHEDULE 13G 4, 10-K 3, 8-A12B/A 3, ARS 3, DEF 14A 3, DRS/A 3, F-1/A 3, F-3 3, 424B3 2, CERT 2, CT ORDER 2, F-1 2, F-3/A 2, S-3 2, SC 13D 2, 20-F/A 1, 4/A 1, 8-A12B 1, 8-K/A 1, D 1, DRS 1, F-4 1, F-4/A 1, POS AM 1, PRE 14A 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 07:52 ET | [8-K](/filings/0001193125-26-356168.md) | 3.01 Delisting notice | 0001193125-26-356168 |
| 2026-08-11 | 08:37 ET | [10-Q](/filings/0001193125-26-343533.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343533 |
| 2026-08-11 | 08:26 ET | [8-K](/filings/0001193125-26-343519.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343519 |
| 2026-08-11 | 08:07 ET | [8-K](/filings/0001193125-26-343482.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-343482 |
| 2026-05-14 | 10:22 ET | [8-K](/filings/0001193125-26-223071.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-223071 |
| 2026-05-12 | 08:56 ET | [8-K/A](/filings/0001193125-26-218290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218290 |
| 2026-05-12 | 08:03 ET | [10-Q](/filings/0001193125-26-218232.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218232 |
| 2026-05-12 | 07:33 ET | [8-K](/filings/0001193125-26-218192.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-218192 |
| 2026-04-09 | 06:51 ET | [DEF 14A](/filings/0001193125-26-148832.md) | Proxy statement, period 2026-04-08 | 0001193125-26-148832 |
| 2026-03-27 | 06:10 ET | [8-K](/filings/0001193125-26-127253.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-127253 |
| 2026-03-19 | 08:52 ET | [10-K](/filings/0001193125-26-115226.md) | Annual report, period 2025-12-31 | 0001193125-26-115226 |
| 2026-03-19 | 08:41 ET | [8-K](/filings/0001193125-26-115211.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115211 |
| 2026-02-17 | 16:30 ET | [8-K](/filings/0001193125-26-054787.md) | 3.01 Delisting notice | 0001193125-26-054787 |
| 2026-01-12 | 08:09 ET | [8-K](/filings/0001193125-26-009829.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009829 |
| 2025-12-29 | 08:54 ET | [8-K](/filings/0001193125-25-332520.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-332520 |
| 2025-11-10 | 16:20 ET | [8-K](/filings/0001193125-25-274319.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274319 |
| 2025-11-10 | 16:15 ET | [10-Q](/filings/0001193125-25-274272.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274272 |
| 2025-08-12 | 07:55 ET | [10-Q](/filings/0001193125-25-178489.md) | Quarterly report, period 2025-06-30 | 0001193125-25-178489 |
| 2025-08-12 | 07:40 ET | [8-K](/filings/0000950170-25-106924.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106924 |
| 2025-07-10 | 06:49 ET | [8-K](/filings/0000950170-25-094921.md) | 8.01 Other events | 0000950170-25-094921 |
| 2025-05-14 | 16:30 ET | [8-K](/filings/0000950170-25-071485.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-071485 |
| 2025-05-13 | 07:57 ET | [10-Q](/filings/0000950170-25-069816.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069816 |
| 2025-05-13 | 07:48 ET | [8-K](/filings/0000950170-25-069811.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069811 |
| 2025-04-08 | 06:41 ET | [DEF 14A](/filings/0000950170-25-051800.md) | Proxy statement, period 2025-05-13 | 0000950170-25-051800 |
| 2025-03-26 | 07:44 ET | [10-K](/filings/0000950170-25-044787.md) | Annual report, period 2024-12-31 | 0000950170-25-044787 |
| 2025-03-26 | 07:38 ET | [8-K](/filings/0000950170-25-044783.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-044783 |
| 2025-01-13 | 06:32 ET | [8-K](/filings/0000950170-25-004523.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004523 |
| 2024-11-12 | 08:13 ET | [10-Q](/filings/0000950170-24-124637.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124637 |
| 2024-11-12 | 07:40 ET | [8-K](/filings/0000950170-24-124598.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124598 |
| 2024-08-13 | 08:19 ET | [10-Q](/filings/0000950170-24-095777.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095777 |
| 2024-08-13 | 08:09 ET | [8-K](/filings/0001193125-24-199430.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-199430 |
| 2024-06-17 | 16:32 ET | [SC 13D/A](/filings/0001104659-24-072315.md) | Ownership report, active investor, amended | 0001104659-24-072315 |
| 2024-06-14 | 16:30 ET | [8-K](/filings/0001193125-24-161662.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-161662 |
| 2024-06-12 | 21:15 ET | [8-K](/filings/0001193125-24-159393.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-159393 |
| 2024-05-23 | 16:16 ET | [8-K](/filings/0001193125-24-145983.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-145983 |
| 2024-05-15 | 16:19 ET | [10-Q](/filings/0000950170-24-060497.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060497 |
| 2024-05-15 | 16:06 ET | [8-K](/filings/0001193125-24-139366.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-139366 |
| 2024-04-24 | 07:30 ET | [DEF 14A](/filings/0001193125-24-108454.md) | Proxy statement, period 2024-05-23 | 0001193125-24-108454 |
| 2024-04-16 | 14:58 ET | [SC 13D/A](/filings/0001104659-24-047715.md) | Ownership report, active investor, amended | 0001104659-24-047715 |
| 2024-04-15 | 07:30 ET | [8-K](/filings/0001193125-24-095508.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-095508 |
| 2024-03-27 | 17:20 ET | [10-K](/filings/0000950170-24-037348.md) | Annual report, period 2023-12-31 | 0000950170-24-037348 |
| 2024-03-27 | 16:08 ET | [8-K](/filings/0001193125-24-078800.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-078800 |
| 2024-01-08 | 07:08 ET | [8-K](/filings/0001193125-24-003868.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003868 |
| 2023-12-18 | 16:10 ET | [6-K](/filings/0001193125-23-297624.md) | Report of a foreign private issuer, period 2023-12-18 | 0001193125-23-297624 |
| 2023-11-29 | 16:15 ET | [6-K](/filings/0001193125-23-285182.md) | Report of a foreign private issuer, period 2023-11-29 | 0001193125-23-285182 |
| 2023-11-20 | 08:45 ET | [SC 13D/A](/filings/0001104659-23-119750.md) | Ownership report, active investor, amended | 0001104659-23-119750 |
| 2023-11-16 | 07:01 ET | [6-K](/filings/0001193125-23-278320.md) | Report of a foreign private issuer, period 2023-11-16 | 0001193125-23-278320 |
| 2023-11-15 | 07:56 ET | [SC 13D/A](/filings/0001104659-23-118442.md) | Ownership report, active investor, amended | 0001104659-23-118442 |
| 2023-11-13 | 07:31 ET | [SC 13D/A](/filings/0001104659-23-116684.md) | Ownership report, active investor, amended | 0001104659-23-116684 |
| 2023-11-08 | 07:06 ET | [SC 13D/A](/filings/0001104659-23-115492.md) | Ownership report, active investor, amended | 0001104659-23-115492 |

Page 1 of 4. [Older](/companies/mreo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.